AbbVie Announces Positive Topline Results from Phase 2 ELATE Trial Evaluating OnabotulinumtoxinA (BOTOX®) for the Treatment of Upper Limb Essential Tremor

AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 2 ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA (BOTOX®) compared to placebo for the treatment of ...

AbbVie succeeds in mid-stage study of neurological disease treatment

AbbVie (NYSE:ABBV) announced that its mid-stage study of Botox (onabotulinumtoxinA) for treating essential tremor in the ...

AbbVie's Botox Shows Improvement In Movement Disorder Study

AbbVie's Phase 2 ELATE trial shows onabotulinumtoxinA improves tremor scores and meets all endpoints, offering a new option ...
The Financial

Actavis Announces FDA Approval of Expanded Label for BOTOX

The FINANCIAL — Actavis plc (NYSE: ACT), which recently completed the acquisition of Allergan, on April 20 announced that the United States Food and Drug Administration (FDA) has approved an expansion ...
WRAL

The Fonz promotes Botox treatment for upper limb spasticity

Henry Winkler, known for his television role as Arthur "The Fonz" Fonzarelli, made it a happy day for many people in the Triangle Tuesday who suffer from upper limb spasticity. Henry Winkler, known ...